Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Myxoid Liposarcoma
100%
FUS-DDIT3
100%
New Humanities
100%
Tumor
60%
Whole Exome Sequencing
40%
Xenograft
40%
COBRA
40%
Quantitative PCR
20%
Insulin-like Growth Factor 1 Receptor (IGF1R)
20%
Aberrations
20%
Western Blot
20%
Subcutaneous Injection
20%
Histology
20%
Compound Heterozygous mutation
20%
Phenotypic Characteristics
20%
Tumor Protein p53 (TP53)
20%
Knock-in Mouse Model
20%
Targeted Treatment
20%
Newly Established
20%
Targeted Therapy
20%
Soluble interleukin-2 Receptor (sIL-2R)
20%
Xenograft Model
20%
Exon 7
20%
Metastatic Risk
20%
PI3K-Akt Pathway
20%
Chimeric Transcription Factor
20%
PIK3CA
20%
Exon 4
20%
Round Cells
20%
Fusion Transcript
20%
Hotspot mutation
20%
Pathognomonic
20%
Pleural Lesion
20%
Myxoid
20%
Spontaneous Immortalization
20%
Molecular Cytogenetics
20%
Established Cell Lines
20%
TERT Promoter
20%
Cytogenetic Profile
20%
Round Cell Component
20%
Fusion Oncogene
20%
SV40 Transformation
20%
C228T
20%
Cell Grow
20%
Molecular Insights
20%
Mouse Xenograft Model
20%
New Cell
20%
NOD SCID
20%
Transcript Type
20%
Biochemistry, Genetics and Molecular Biology
FUS
100%
Exome Sequencing
66%
Naja
66%
Western Blot
33%
Promoter Region
33%
Wild Type
33%
Transcription Factors
33%
Karyotype
33%
Exon
33%
Knockout Mouse
33%
Cytogenetics
33%
Experimental Model
33%
Protein Kinase B
33%
Simian Virus 40
33%
Fusion Transcript
33%
Gene Fusion
33%
Preclinical Study
33%
NOD SCID Gamma Mouse
33%
Reverse Transcription Polymerase Chain Reaction
33%
Targeted Therapy
33%
Medicine and Dentistry
Cell Line
100%
Myxoid Liposarcoma Cell Line
100%
Xenograft
50%
Neoplasm
37%
Exome Sequencing
25%
Targeted Therapy
25%
Myxosarcoma
25%
Subcutaneous Injection
12%
Exon
12%
Promoter Region
12%
Karyotype
12%
Western Blot
12%
Transcription Factors
12%
Cell Component
12%
SV40
12%
PI3K/AKT Pathway
12%
Aneuploidy
12%
Liposarcoma
12%
Gene Fusion
12%
Pathognomonic
12%
Reverse Transcription Polymerase Chain Reaction
12%
Histology
12%
Knockout Mouse
12%